LUN95-1
A Phase III Study of Gemcitabine +Cisplatin vs Cisplatin Alone in Patients with Metastatic Non-Small Cell Lung Cancer
Manuscripts/Articles:
- Sandler AB, Nemunaitis J, Denham C, von Pawel J, Cormier Y, Gatzemeier U, Mattson K, Manegold C, Palmer MC, Gregor A, Nguyen B, Niyikiza C, Einhorn LH. Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol. 2000 Jan;18(1):122-30. See abstract.
Abstracts/Posters/Presentations:
- Sandler A, Nemunaitis J, Dehnam C, Cormier Y, von Pawel J, Niyikiza C, Nguyen B, Einhorn L. Phase III Study of Cisplatin (C) With or Without Gemcitabine (G) in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC). A Hoosier Oncology Group Trial LUN95-1. Accepted to the ESMO annual meeting November 23, 1998, Athens, Greece.
Facebook
Hoosier Cancer Research Network on Facebook
Linked In
You Tube
Twitter